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Apart from kidney, where renin synthesis takes place in all mammals, the submaxillary gland (SMG) of most mouse 
strains constitutes an important source of an isoenzyme, renin-2, that is highly homologous to renal renin, but unglycosyl- 
ated [(1982) Nature 298, 90-921. This unique phenotype is due to the presence of an extra copy of the renin gene. A 
puzzling observation is that (pro)renin-2 cannot be detected in the kidney of these animals, although both mRNAs accu- 
mulate at similar levels [(1985) Proc. Natl. Acad. Sci. USA 82, 6196-6200]. In order to investigate whether (pro)renin-2 
expression is detectable in mouse heterologous cell lines we transfected the renin-2 cDNA into AtT20 (pituitary cortico- 
trope) and BTG9A (hepatoma) cells. Stable clones expressing renin were obtained in both cases. BTG9A cells secreted 
only prorenin while AtT20 cells secreted prorenin and active renin. In addition, in AtT20 cells the secretion of active 
renin was stimulated by 8-Br CAMP. Our results show that unglycosylated (pro)renin-2 can be expressed and secreted 
in two murine cell lines. Moreover, it is correctly processed to active renin and secreted upon stimulation in AtT20 cells. 
Renin; Glycosylation, N-linked; Gene expression; Precursor processing; (AtT20 cell, Hepatoma) 
1. INTRODUCTION 
Renin catalyses the rate-limiting step in the 
regulation of blood pressure and saline balance. It 
is synthesized as an inactive precursor, prorenin, 
and converted to active renin by proteolytic 
cleavage following two basic residues [l]. In all 
species, renin gene expression is highest in the jux- 
taglomerular cells (JGC) of the kidney. However, 
in most mouse strains, a high level of renin expres- 
sion is also observed in the submaxillary gland 
(SMG). These mice bear an additional copy of the 
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renin gene (Ren2), the product of which is an un- 
glycosylated thermosensitive isoenzyme (remin-2), 
96% homologous to the glycosylated and thermo- 
stable renal renin (renin-1) [3,4]. The pre- 
dominance of renin-2 in SMG is perfectly cor- 
related with the greater efficiency of Ren2 pro- 
moter in this tissue. In contrast, in the kidney 
and Ren2 mRNAs are present at the same level but 
only the protein product of Renl is detectable 
[2,3]. Specific regulation of translation or RNA 
stability seems unlikely, since non-coding 5 ‘- and 
3 ‘-sequences are highly homologous in both 
mRNAs [1,5]. Therefore, it is probable that the 
absence of renin-2 isoenzyme in kidney is due to a 
posttranslational 
intracellular compartment or 
after secretion. Interestingly, 
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JGC-derived cell lines are not available. The mouse 
pituitary corticotrope cell line AtT20 is suitable for 
this study, since it has the ability to carry out the 
posttranslational processing of its endogenous 
precursor proopiomelanocortin (POMC) and also 
other foreign precursors [6,7]. In addition, the two 
secretory pathways which have been described for 
JGC [8] also exist in AtT20 cells: a constitutive 
pathway where precursors are rapidly secreted, the 
other being of the regulated type in which precur- 
sor processing takes place and secretion of granule 
content can be stimulated by secretagogues. Final- 
ly, we have also used a constitutive secreting cell 
line, BTG9A, derived from a mouse hepatoma [9]. 
Here, we report results of transfection of both 
cell lines with renin-2 cDNA. We have analysed in 
detail the kinetics of secretion and maturation of 
prorenin in AtT20 cells. 
2. MATERIALS AND METHODS 
BTG9A and AtT20/D16v cells were grown in RPM1 and 
DMEM media, respectively, supplemented with 10% fetal calf 
serum (FCS). Gene transfer was performed by the calcium phos- 
phate coprecipitation method [9]. 48 h after transfection selec- 
tive medium was added and stably transformed clones were 
isolated after 3-7 weeks of selection. 
cDNA cloning of SMG preprorenin has been described [3]. 
The 5 ’ poly(G) tail was deleted by in vitro mutagenesis and the 
cDNA fragment was introduced into the SmaI site of pMSG 
(Pharmacia) under the control of MMTV promoter 
(pMSG.Rnl4, fig.la). This plasmid was used to transfect 
BTG9A cells and selection was performed through EcoGPT (E. 
coli guanosine phosphoribosyltransferase) in standard HAT 
(hypoxanthine, aminopterin, thymidine) medium [9]. In the 
case of AtT20 cells EcoGPT is unsuitable for selection [lo], 
therefore hph gene (hygromycin B phosphotransferase; &WI1 
fragment from plasmid pAG452.2 [1 11) was introduced into the 
WeI site of pMSG.Rnl4 (pMH.Rnl4, fig.lb). Selective 
medium contained 150pg/ml of hygromycin B (Boehringer). 
Preprorenin cDNA was also exchanged with the Cat gene in 
pRSVCAT [12], (pRSV.Rnl4, fig.lc). This construction was 
transfected into AtT20 cells and transient expression was 
assayed 65 h after transfection. 
Renin activity was determined by radioimmunoassay (RIA) 
of angiotensin I (AI) generated after 1 h at 37°C in the presence 
of excess substrate from plasma of nephrectomised rats [13]. 
Total renin activity (prorenin plus active renin) was determined 
after trypsin activation [14]. Prorenin values were obtained 
from the difference between activities before and after trypsin 
treatment. Intracellular ACTH immunoreactivity was deter- 
mined by 15% SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) on 5 N acetic acid cell extracts and elution of 1 mm long 
gel slices in RIA buffer [IS]. RNA preparation and Northern 
blotting have been previously described [16,17]. 
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Fig.1. Diagram of preprorenin expression plasmids. Rn14, 
preprorenin-2 cDNA; MMTV LTR, MMTV long terminal 
repeat; polyA + splice, SV40 small t antigen splice site and 
polyadenylation site; Eco GPT, E. coli guanosine 
phosphoribosyl transferase; Amp R, ampicillin resistance gene; 
TK promoter and TK polyA + splice, herpes simplex virus 
timidine kinase promoter, polyadenylation and splice sites; hph, 
hygromycin B phosphotransferase. 
3. RESULTS AND DISCUSSION 
Two renin expression vectors, pMSG.Rnl4 and 
pMH.Rnl4 (fig.la,b), were used to transfect BTG 
71 
Volume 245, number 1,2 FEBS LETTERS March 1989 
and AtT20 cells, respectively. After selection, 
stable clones expressing renin were obtained for 
both cell types. Different clones were screened for 
total renin activity in the supernatant (after trypsin 
pretreatment). Two clones, BT.MSG.Rnl4 and 
At.MH.Rnl4 were selected for further studies, 
since their level of expression was among the 
highest tested. 
Fig.2 shows Northern blot analysis of renin ex- 
pression in both control and renin-expressing cells. 
RNA levels are approx. 500-times lower than those 
of SMG from male mice (estimated by dot blot; not 
shown). The size of the RNA corresponds to the ex- 
pected 1400 bp of preprorenin RNA + 800 bp of 
SV40 sequences. Control cells do not produce 
detectable levels of renin mRNA. 
BT.MSG.Rnl4 cells produced only prorenin 
(after 24 h induction with 1 pM dexamethasone; 
not shown). In contrast, At.MH.Rnl4 cells 
secreted both prorenin and renin (fig.3). Dexa- 
methasone was not used to stimulate MMTV pro- 
moter in AtT20 cells because it inhibits secretion in 
these cells [ 181. The kinetics of prorenin and renin 
secretion were studied in detail in At.MH.Rnl4 
cells. Cells were incubated in the presence or 
absence of the secretagogue B-Br CAMP. Fig.3 
shows basal and stimulated renin (a) or prorenin 
Fig. 2. Northern blot analysis of control and transfected cells 
total RNA. 15 ,ug total RNA from BTG9A cells (lane 2), AtT20 
cells (lane 3), BT.MSG.Rnl4 cells (lane 4), At.MH.Rnl4 cells 
(lane 5) and 2 fig total male SMG mouse (lane 1) were probed 
with “P-labeled preprorenin cDNA. 
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Fig. 3. Kinetics of prorenin and renin secretion of At.MH.Rnl4 
cells. Cells were cultured up to 80% confluence in 6-well plates. 
The medium was replaced at time = 0 by fresh medium with or 
without 5 mM 8-Br CAMP. Aliquots were taken at different 
times and assayed for renin activity (a) or total renin activity 
(after trypsin treatment). Prorenin values (b) were calculated by 
subtraction of renin activities from total renin activity. Renin 
activity is expressed as /cg/ml of AI generated after 1 h incuba- 
tion at 37OC with renin substrate. Values represent means * SD 
of three different experiments, each assayed in duplicate. 
(b) accumulation in the culture medium. In the 
presence of secretagogue there is an increase in 
secretion rate of active renin; interestingly, there is 
also a significant rise in precursor secretion. This 
elevation appears to arise from the regulated 
12 
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secretory granule pool, since 8-Br CAMP is known 
not to affect constitutive secretion. 
Previous work has pointed out that human renin 
is completely processed in the regulated secretory 
pool of AtT20 cells [ 19,201. A possible explanation 
for this difference was that we had used a variant 
AtT20 cell line with diminished processing capaci- 
ty. Fig.4a shows that he parental cell line has a 
normal processing capacity, since the majority of 
the intracellular POMC-like immunoreactivity cor- 
responds to ACTH and glycosylated ACTH (peaks 
3,4). However, for clone At.MH.Rnl4 these peaks 
appear less significant with respect o POMC peaks 
1,2 (fig.4b). Therefore, the reduced prorenin 
maturation observed for this clone correlates with 
diminution of endogenous precursor processing. 
This cannot be explained by competition of pro- 
renin with the endogenous precursor POMC as has 
been described for proneuropeptide Y [7], since 
renin expression in these cells is many orders of 
magnitude lower than that of endogenous POMC 
(estimated by cell labeling, immunoprecipitation 
and PAGE; not shown). It seems probable that a 
cellular variation occurred during subcloning, in- 
volving a general decrease in maturation capacity. 
This result emphasizes the need to ascertain the 
processing capacity of each stable clone. 
The possibility could still not be ruled out that 
the incomplete maturation observed was due to 
some specific feature of prorenin-2 as a substrate 
of AtT20-processing enzyme(s) (i.e. the absence of 
glycosylation, an amino acid mutation neighbour- 
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Fig. 5. Transient expression of prorenin and renin from 
pRSV.Rnl4 transfected AtT20 cells. 65 h after transfection with 
pRSV.Rnl4, media were replaced by fresh medium with or 
without 5 mM 8-Br CAMP. At.MH.Rnl4 cells were also plated 
at the same density and media replaced + 8-Br CAMP. Media 
were collected after 4 h and assayed for renin activity (hatched 
bars) or total renin activity (after trypsin treatment). Prorenin 
values (empty bars) were calculated by subtraction of renin ac- 
tivities from total renin activity. Renin activity is expressed as 
,ug/ml of AI generated after 1 h incubation at 37°C with renin 
substrate. Values represent means f SD of five different ex- 
Fig. 4. ACTH immunoreactivity of AtT20 intracellular extracts. 
Acetic acid (5 N) extracts from AtT20 (a) or At.MH.Rnl4 (b) 
cells were analysed by 15% SDS-PAGE, 1 mm long gel slices 
were eluted and ACTH immunoreactivity (IR) was determined. 
Peaks: 1,2, glycosylated and unglycosylated POMC; 3,4, 
glycosylated and unglycosylated ACTH, respectively. periments, each assayed in duplicate. 
ug Al/ml. 
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ing the processing site, etc.). In order to obtain 
results independent of subcloning variations, we 
have analysed transient renin expression. For this 
purpose we have transfected the AtT20 cells with 
preprorenin-2 cDNA under the control of RSV 
promoter (pRSV.Rnl4, fig.lc), which is much 
stronger than MMTV promoter in these cells [IO]. 
Fig.5 shows that as much prorenin as active renin 
was secreted from these cells under non-stimulating 
conditions. In the presence of secretagogue only 
active renin release was stimulated, indicating the 
complete maturation of prorenin in the 8-Br CAMP 
responsive secretory pool. Therefore, renin-2 ap- 
parently behaves similarly to human renin in 
AtT20 cells [ 19,201. 
The present data demonstrate that in AtT20 
cells, mouse prorenin-2 is appropriately stored, 
processed and released upon stimulation with 8-Br 
CAMP. This indicates that in these cells un- 
glycosylated renin-2 is stable and not (or not com- 
pletely) proteolytically degraded. Moreover, in the 
constitutive secreting hepatoma cell line prorenin-2 
is also correctly released, although exclusively in 
the precursor state. The apparent lack of 
(pro)renin-2 in JGC of two renin gene-bearing mice 
could therefore be due to some cell-specific fac- 
tor(s) which would affect intracellular (pro)renin-2 
stability. 
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